Isoray To Announce Second Quarter Fiscal 2021 Financial Results on February 9, 2021
Isoray, Inc. (NYSE AMERICAN: ISR) will host a conference call on February 9, 2021, at 4:30 p.m. ET to discuss its financial results for Q2 FY 2021, which ended on December 31, 2020.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Isoray, Inc. (NYSE AMERICAN: ISR) will host a conference call on February 9, 2021, at 4:30 p.m. ET to discuss its financial results for Q2 FY 2021, which ended on December 31, 2020. A press release with the financial results will be issued after the market close on the same day. The conference call can be accessed via phone or a live webcast, which will remain available until May 9, 2021. Isoray is recognized for its innovation in brachytherapy, specifically in the production of Cesium-131 seeds.
Positive
- Isoray is the sole producer of Cesium-131 brachytherapy seeds, indicating a unique market position.
- The upcoming conference call may provide insights into financial growth and future strategies.
Negative
- None.
Details
News Market Reaction – ISR
The recorded move for ISR in the trading session of this news was +3.87%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Call is Tuesday, February 9, 2021 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, Wash., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that it will host a conference call to discuss its financial results for the second quarter fiscal year 2021 ended December 31, 2020 on Tuesday, February 9, 2021, at 4:30 p.m. Eastern Time. The Company will issue a press release announcing its financial results for the second quarter fiscal year 2021 after the close of the U.S. stock markets on February 9, 2021.
To listen to the conference call, please dial 877-407-8035. For callers outside the U.S., please dial 201-689-8035.
The conference call will be simultaneously webcast and can be accessed at https://www.webcaster4.com/Webcast/Page/2199/39694. The webcast will be available until May 9, 2021 following the conference call.
About Isoray
Isoray, Inc., through its subsidiary, Isoray Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy treatment options throughout the body. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Join us on Facebook and follow us on Twitter @Isoray.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.